返回 Agenda
Session Chair(s)
Qing Zuraw, MD, MBA
Covance, Inc., United States
Speaker(s)
Risk-Based Quality Management in Clinical Trials: A Risk Proportionate Approach
David Cockburn
European Medicines Agency, Netherlands
Head of Manufacturing and Quality Compliance Service
Risk-Based Monitoring from the Global Perspectives
Qing Zuraw, MD, MBA
Covance, Inc., United States
Jane LIN, MD
Johnson & Johnson Medical (China) Ltd., China
VP, Strategic Medical Affairs
Shuting Li, MD
GCP Alliance, China, China
Deputy Director
Risk-Based Monitoring Current Practice & Challenges
Yanxia Huang
MSD R&D (China) Co., Ltd, China
Vice President, Head of Clinical Operations, MSD